Abstract
A 35-year-old male abusing intravenous (IV) xylazine-laced fentanyl presented with bilateral forearm wounds. His wounds extended from the wrist to the proximal forearm with exposed muscles and tendons. He was treated with intravenous antibiotics, multiple surgical debridements, and negative pressure wound therapy. He left against medical advice (AMA) and returned with similar, smaller wounds nine months later. The patient was treated and again left AMA and has not followed up since. Xylazine is a veterinary tranquilizer often added to fentanyl to prolong and enhance its effects, whose presence has markedly increased in the illicit drug markets in the United States. It can result in extensive tissue loss from direct toxicity of the drug and/or concomitant infection. Xylazine use may increase morbidity in persons who inject drugs relating to the high prevalence of skin ulcers, soft tissue abscesses, and risk of serious infection necessitating surgical management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
